Association of Systemic Inflammatory Biomarkers (NLR, MLR, PLR, SII, SIRI) with Preeclampsia-Related Kidney Injury: A

Li-Na Gao1,2, Dong Yan2, Xiao-Hui Liu2

  • 1The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, People's Republic of China.

PubMed

Insights

Inflammation markers like monocyte-to-lymphocyte ratio (MLR) and systemic inflammation response index (SIRI) are linked to acute kidney injury (AKI) in preeclampsia (PE). Elevated MLR is a key risk factor, especially in early-onset PE.

Area of Science:

  • Obstetrics and Gynecology
  • Nephrology
  • Immunology

Background:

  • Preeclampsia (PE) affects 7-13% of pregnancies, with acute kidney injury (AKI) being a severe complication.
  • PE-AKI is associated with long-term chronic kidney disease.
  • Inflammation plays a critical role in PE pathogenesis and progression.

Purpose of the Study:

  • To investigate the association between inflammation indices and the risk of PE-AKI.
  • To evaluate the clinical utility of five inflammation markers in predicting PE-AKI.
  • To identify specific inflammatory markers most strongly associated with PE-AKI.

Main Methods:

  • Retrospective observational study of 4071 PE patients (2013-2023).
  • Analysis of neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI).
  • Multivariate logistic regression and restricted cubic spline models to assess associations and dose-response relationships.

Main Results:

  • 7.13% of PE patients developed AKI.
  • Significant positive associations were found between all tested inflammatory indices and PE-AKI risk.
  • Monocyte-to-lymphocyte ratio (MLR) showed the strongest independent correlation with PE-AKI (highest tertile OR = 7.24).
  • Elevated MLR was a prominent risk factor in early-onset PE and complicated cases.

Conclusions:

  • MLR and SIRI are positively associated with PE-AKI risk, particularly in early-onset and complicated PE.
  • These findings support the clinical utility of MLR and SIRI as predictive biomarkers for PE-AKI.
  • Further research focusing on monocyte-mediated inflammatory mechanisms is warranted.
Abstract

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
504
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
203
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
581
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
541
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
827